Clinical Trials for Tarceva (OSI-774; erlotinib)

2 Open Trials

Trial TypeProtocol No. &
Open Date
Summary
TreatmentVICCTHN1242
10/24/2012
A Phase IB, Multi-Center,Open-Label Study of the MTOR Kinase Inhibitor CC-223 in Combination with Erlotinib or Oral Azacitidine in Advanced Non-Small Cell Lung Cancer
TreatmentVICCGI1173
07/31/2012
A Phase 1 Study of Gemcitabine, Dasatinib and Erlotinib in Patients with Advanced Pancreatic Carcinoma

Back to Find By Drug

You do not have JavaScript enabled. This site works better with JavaScript turned on.